Paul H. Tolerico

A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial

William A. Gray, Koen Keirse, Yoshimitsu Soga et al. · The Lancet · 2018 · 279 citations

Zilver Ptx, Paclitaxel-eluting Stent, Endovascular Technique +8

Prevalence of Fracture and Fragment Embolization of Bard Retrievable Vena Cava Filters and Clinical Implications Including Cardiac Perforation and Tamponade

William Nicholson, W. J. Nicholson, Paul H. Tolerico et al. · Archives of Internal Medicine · 2010 · 220 citations

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

Muthiah Vaduganathan, Robert A. Harrington, Gregg W. Stone et al. · Journal of the American College of Cardiology · 2017 · 56 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +8

Alterations in levels of Na(+)-K(+)-ATPase isoforms in heart, skeletal muscle, and kidney of diabetic rats

Yuk-Chow Ng, Paul H. Tolerico, C. B. Book · American Journal of Physiology-Endocrinology and Metabolism · 1993 · 45 citations

-Atpase Isoforms, -Atpase Subunit Isoforms, Insulin Signaling +19

Impact of Drug Eluting Stent Length on Outcomes of Percutaneous Coronary Intervention (from the EVENT Registry)

Ronald Caputo, Ankush Goel, Michael Pencina et al. · The American Journal of Cardiology · 2012 · 36 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Event Registry +11